Urologix, Inc. (ULGX) Reports Q1 Loss of $0.09
Tweet
Share
E-mailGet Alerts ULGX Hot Sheet
Price: $0.00 --0%
Financial Fact:
Net loss per common share - basic (in dollars per share): -0.02
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Net loss per common share - basic (in dollars per share): -0.02
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Urologix, Inc. (NASDAQ: ULGX) reported Q1 EPS of ($0.09), versus ($0.09) reported last year. Revenue for the quarter came in at $3.14 million, versus $3.35 million reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
- Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
